Literature DB >> 8262550

Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27.

K Sugita1, J D Dasgupta, Y Nojima, K Agematsu, S F Schlossman, C Morimoto.   

Abstract

CD27 is a T-cell surface antigen expressed on the majority of peripheral T cells and belongs to a newly defined receptor family including the low-affinity nerve growth factor receptor, tumour necrosis factor (TNF) receptors, the B-cell activation antigen CD40, and the Fas antigen. Although the function of CD27 has not been defined, several experimental observations support the notion that this molecule plays an important role in the process of T-cell activation. In this paper, we have demonstrated that a rapid hyperphosphorylation of CD27 is induced by a cyclic AMP-inducing agent, forskolin, and a membrane-permeable cAMP analogue, 8-bromo-cAMP, as well as phorbol 12-myristate 13-acetate (PMA). In addition, increased phosphorylation of CD27 in T-cell activation either via CD2 or CD3 pathways was strongly suppressed by a cyclic nucleotide-dependent kinase inhibitor, H-8, but only slightly by a protein kinase C inhibitor, staurosporine. These results suggest that protein kinase A might be a key kinase responsible for CD27 phosphorylation in the process of T-cell activation. CD27 is the first T-cell surface antigen demonstrated to be phosphorylated by the cyclic AMP-protein kinase A-mediated pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262550      PMCID: PMC1422191     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Molecular events mediating T cell activation.

Authors:  A Altman; K M Coggeshall; T Mustelin
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

2.  Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors.

Authors:  R de Jong; W A Loenen; M Brouwer; L van Emmerik; E F de Vries; J Borst; R A van Lier
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

3.  CD27 expression by a distinct subpopulation of human B lymphocytes.

Authors:  D Maurer; W Holter; O Majdic; G F Fischer; W Knapp
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

4.  The 1A4 molecule (CD27) is involved in T cell activation.

Authors:  K Sugita; Y Torimoto; Y Nojima; J F Daley; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

5.  Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.

Authors:  W L Farrar; S W Evans; U R Rapp; J L Cleveland
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

6.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

7.  Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.

Authors:  W C Hahn; Y Rosenstein; S J Burakoff; B E Bierer
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

Review 8.  A new superfamily of cell surface proteins related to the nerve growth factor receptor.

Authors:  S Mallett; A N Barclay
Journal:  Immunol Today       Date:  1991-07

9.  Activation of membrane protein-tyrosine phosphatase involving cAMP- and Ca2+/phospholipid-dependent protein kinases.

Authors:  D L Brautigan; F M Pinault
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

Authors:  I Stamenkovic; E A Clark; B Seed
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.